Company · CIK 0001644963 · SIC 2834 — Pharmaceutical Preparations · OTC
AVENUE THERAPEUTICS, INC. · ATXI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2019 PForm 4 → | Feb 25, 4:13 pm EST | Neil HerskowitzDirector | 5,000 | $5.46 | $27,300 | 91,663 | +5.77% | plan? |
| Feb 4, 2019 PForm 4 → | Feb 6, 4:31 pm EST | Neil HerskowitzDirector | 8,850 | $5.88 | $52,045 | 86,663 | +11.4% | plan? |
| Jan 30, 2019 PForm 4 → | Feb 1, 12:48 pm EST | Neil HerskowitzDirector | 650 | $5.91 | $3,842 | 77,813 | +0.84% | plan? |
| Jan 28, 2019 PForm 4 → | Jan 30, 4:18 pm EST | Neil HerskowitzDirector | 10,000 | $5.90 | $58,999 | 77,163 | +14.9% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 12, 1:15 pm EST | Jeffrey PaleyDirector | 15,000 | $5.24 | $78,554 | 79,663 | +23.2% | plan? late |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:50 pm EDT | Joseph Walter VazzanoVP Finance & Corp. Controller | 30,000 | — | — | 61,351 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:48 pm EDT | Lucy LuPresident, CEO, Director | 250,000 | — | — | 807,333 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:46 pm EDT | Lindsay A Rosenwald M.D.Director | 14,663 | — | — | 84,663 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:45 pm EDT | Neil HerskowitzDirector | 14,663 | — | — | 67,163 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:43 pm EDT | Jay D KranzlerDirector | 14,663 | — | — | 64,663 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:42 pm EDT | Scott ReinesInterim Chief Medical Officer | 10,000 | — | — | 45,000 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:40 pm EDT | Michael S WeissDirector | 14,663 | — | — | 24,663 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:39 pm EDT | Jeffrey PaleyDirector | 14,663 | — | — | 64,663 | — | plan? |
| Aug 7, 2018 GForm 4 → | Aug 8, 9:37 pm EDT | Akhtar SamadDirector | 14,663 | — | — | 64,663 | — | plan? |
| Jun 28, 2018 AForm 4 → | Jun 28, 1:09 pm EDT | Joseph Walter VazzanoVP Finance & Corp. Controller | 1,351 | $3.66 | $4,945 | 31,351 | — | plan? |
| Jun 14, 2018 AForm 4 → | Jun 15, 1:19 pm EDT | Lucy LuPresident, CEO, Director | 5,000 | $4.00 | $20,000 | 557,333 | — | plan? |
| Jun 8, 2018 PForm 4 → | Jun 11, 5:37 pm EDT | Lindsay A Rosenwald M.D.Director | 5,234 | $4.34 | $22,716 | 25,234 | +26.2% | plan? |
| Jun 1, 2018 PForm 4/A → | Jun 12, 5:31 pm EDT | Lindsay A Rosenwald M.D.Director | 50,000 | $4.28 | $214,143 | 70,000 | +250% | plan? |
| Apr 25, 2018 PForm 4 → | Apr 25, 4:30 pm EDT | Neil HerskowitzDirector | 1,000 | $3.80 | $3,800 | 52,500 | +1.94% | plan? |
| Oct 17, 2017 PForm 4 → | Oct 18, 12:19 pm EDT | Neil HerskowitzDirector | 1,000 | $5.01 | $5,010 | 51,500 | +1.98% | plan? |
| Oct 9, 2017 PForm 4 → | Oct 10, 8:27 am EDT | Neil HerskowitzDirector | 500 | $5.24 | $2,620 | 50,500 | +1.00% | plan? |
| Oct 4, 2017 PForm 4 → | Oct 10, 8:36 am EDT | Lindsay A Rosenwald M.D.Director | 10,000 | $5.58 | $55,817 | 20,000 | +100% | plan? late |
| Sep 28, 2017 AForm 4 → | Oct 2, 6:09 am EDT | Lucy LuPresident, CEO, Director | 4,000 | $5.20 | $20,800 | 552,333 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.